MedPath

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Recruiting
Conditions
Autoimmune Encephalitis
Interventions
Diagnostic Test: FDG-PET
Registration Number
NCT06019975
Lead Sponsor
University of Milano Bicocca
Brief Summary

The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is:

•is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Diagnosis of autoimmune encephalitis according to clinical criteria
  • Brain magnetic resonance imaging performed between clinical presentation and treatment
  • Cerebrospinal fluid analysis performed between clinical presentation and treatment
  • Brain FDG-PET performed between clinical presentation and treatment
  • Autoantibodies testing performed between clinical presentation and treatment
Exclusion Criteria
  • Refusal to give consent for the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Autoimmune Encephalitis patientsFDG-PETPatients with autoimmune encephalitis admitted to the centers, who underwent a brain FDG-PET during the course of their disease trajectory.
Primary Outcome Measures
NameTimeMethod
SPM analysis of brain metabolic patternup to 6 months

Pattern of brain metabolism in patients with autoimmune encephalitis compared with healthy controls and patients with Alzheimer's disease, drawn from validated published databases

Secondary Outcome Measures
NameTimeMethod
Sensitivity of basal ganglia hypermetabolismup to 6 months

Sensitivity of basal ganglia hypermetabolism for the diagnosis of autoimmune encephalitis

Diagnostic delayup to 6 months

Comparison of diagnostic delay with and without FDG-PET

Trial Locations

Locations (6)

Fondazione IRCCS Mondino

🇮🇹

Pavia, Lombardia, Italy

Fondazione IRCCS San Gerardo dei Tintori

🇮🇹

Monza, Monza E Della Brianza, Italy

Fondazione IRCCS Istituto Neurologico "Carlo Besta"

🇮🇹

Milano, Italy

Azienda Sanitaria Universitaria Friuli Centrale

🇮🇹

Udine, Friuli Venezia Giulia, Italy

Ospedale San Paolo

🇮🇹

Milano, Italy

IRCCS Ospedale Policlinico San Martino

🇮🇹

Genova, Liguria, Italy

© Copyright 2025. All Rights Reserved by MedPath